|
1
|
Sasako M, Inoue M, Lin JT, Khor C, Yang HK
and Ohtsu A: Gastric Cancer Working Group Report. Jpn J Clin Oncol.
40(Suppl 1): i28–i37. 2010. View Article : Google Scholar
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
3
|
Yang L: Incidence and mortality of gastric
cancer in China. World J Gastroenterol. 12:17–20. 2006.
|
|
4
|
AIRTUM Working Group. Italian cancer
figures, report 2011: survival of cancer patients in Italy.
Epidemiol Prev. 35(5–6 Suppl 3): 1–200. 2011.(In Italian).
|
|
5
|
Amadori D, Cascinu S, Conte PF and Ibrahim
T: Bone metastases. Osteo-Oncology Textbook. Cisalpina Grafiche and
Milanese S Giuliano: pp. 200–201. 2010
|
|
6
|
Kim HS, Yi SY, Jun HJ, et al: Clinical
outcome of gastric cancer patients with bone marrow metastases.
Oncology. 73:192–197. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kobayashi M, Okabayashi T, Sano T and
Araki K: Metastatic bone cancer as a recurrence of early gastric
cancer - characteristics and possible mechanisms. World J
Gastroenterol. 11:5587–5591. 2005.PubMed/NCBI
|
|
8
|
Batson OV: The function of the vertebral
veins and their role in the spread of metastases. 1940. Clin Orthop
Relat Res. (312): 4–9. 1995.PubMed/NCBI
|
|
9
|
Devkaran B, Jhobta R and Verma DK: Bony
metastasis of gastric adenocarcinoma. Saudi J Gastroenterol.
15:137–138. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Boyle WJ, Simonet WS and Lacey DL:
Osteoclast differentiation and activation. Nature. 423:337–342.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hofbauer LC, Neubauer A and Heufelder AE:
Receptor activator of nuclear factor-kappaB ligand and
osteoprotegerin: potential implications for the pathogenesis and
treatment of malignant bone diseases. Cancer. 92:460–470. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kobayashi K, Takahashi N, Jimi E, et al:
Tumor necrosis factor alpha stimulates osteoclast differentiation
by a mechanism independent of the ODF/RANKL-RANK interaction. J Exp
Med. 191:275–286. 2000. View Article : Google Scholar
|
|
13
|
Walsh MC and Choi Y: Biology of the TRANCE
axis. Cytokine Growth Factor Rev. 14:251–263. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
McGonigle JS, Giachelli CM and Scatena M:
Osteoprotegerin and RANKL differentially regulate angiogenesis and
endothelial cell function. Angiogenesis. 12:35–46. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Sfiridaki K, Pappa CA, Tsirakis G, et al:
Angiogenesis-related cytokines, RANKL, and osteoprotegerin in
multiple myeloma patients in relation to clinical features and
response to treatment. Mediators Inflamm. 2011:8675762011.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Min JK, Cho YL, Choi JH, et al: Receptor
activator of nuclear factor (NF)-kappaB ligand (RANKL) increases
vascular permeability: impaired permeability and angiogenesis in
eNOS-deficient mice. Blood. 109:1495–1502. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Carlevaro MF, Cermelli S, Cancedda R and
Descalzi Cancedda F: Vascular endothelial growth factor (VEGF) in
cartilage neovascularization and chondrocyte differentiation:
auto-paracrine role during endochondral bone formation. J Cell Sci.
113:59–69. 2000.
|
|
18
|
Vidal O, Metges JP, Elizalde I, et al:
High preoperative serum vascular endothelial growth factor levels
predict poor clinical outcome after curative resection of gastric
cancer. Br J Surg. 96:1443–1451. 2009. View
Article : Google Scholar
|
|
19
|
Roato I, Grano M, Brunetti G, et al:
Mechanisms of spontaneous osteoclastogenesis in cancer with bone
involvement. FASEB J. 19:228–230. 2005.PubMed/NCBI
|
|
20
|
Brianza S, D’Amelio P, Cerrato M, Bignardi
C, Grimaldi A, Pescarmona G and Isaia G: A dedicated image analysis
software tool for the evaluation of the resorption activity of
cultured osteoclasts. JIST. 52:30508-1–30508-9. 2008. View Article : Google Scholar
|
|
21
|
Roato I, D’Amelio P, Gorassini E, et al:
Osteoclasts are active in bone forming metastases of prostate
cancer patients. PLoS One. 3:e36272008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
D’Amelio P, Roato I, D’Amico L, et al:
Bone and bone marrow pro-osteoclastogenic cytokines are
up-regulated in osteoporosis fragility fractures. Osteoporos Int.
22:2869–2877. 2011.PubMed/NCBI
|
|
23
|
Roato I, Brunetti G, Gorassini E, et al:
IL-7 up-regulates TNF-alpha-dependent osteoclastogenesis in
patients affected by solid tumor. PLoS One. 1:e1242006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Roato I, Gorassini E, Buffoni L, et al:
Spontaneous osteoclastogenesis is a predictive factor for bone
metastases from non-small cell lung cancer. Lung Cancer.
61:109–116. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Colucci S, Brunetti G, Rizzi R, et al: T
cells support osteoclastogenesis in an in vitro model derived from
human multiple myeloma bone disease: the role of the OPG/TRAIL
interaction. Blood. 104:3722–3730. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kudo O, Sabokbar A, Pocock A, Itonaga I,
Fujikawa Y and Athanasou NA: Interleukin-6 and interleukin-11
support human osteoclast formation by a RANKL-independent
mechanism. Bone. 32:1–7. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Howlett M, Chalinor HV, Buzzelli JN, et
al: IL-11 is a parietal cell cytokine that induces atrophic
gastritis. Gut. 61:1398–1409. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Necula LG, Chivu-Economescu M,
Stanciulescu EL, et al: IL-6 and IL-11 as markers for tumor
aggressiveness and prognosis in gastric adenocarcinoma patients
without mutations in Gp130 subunits. J Gastrointestin Liver Dis.
21:23–29. 2012.PubMed/NCBI
|
|
29
|
Schinke T, Schilling AF, Baranowsky A, et
al: Impaired gastric acidification negatively affects calcium
homeostasis and bone mass. Nat Med. 15:674–681. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Juarez P and Guise TA: TGF-β in cancer and
bone: implications for treatment of bone metastases. Bone.
48:23–29. 2011.
|
|
31
|
Maehara Y, Kakeji Y, Kabashima A, et al:
Role of transforming growth factor-beta 1 in invasion and
metastasis in gastric carcinoma. J Clin Oncol. 17:607–614.
1999.PubMed/NCBI
|
|
32
|
Holen I and Shipman CM: Role of
osteoprotegerin (OPG) in cancer. Clin Sci. 110:279–291. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ito R, Nakayama H, Yoshida K, et al:
Expression of osteoprotegerin correlates with aggressiveness and
poor prognosis of gastric carcinoma. Virchows Arch. 443:146–151.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Macsai CE, Foster BK and Xian CJ: Roles of
Wnt signalling in bone growth, remodelling, skeletal disorders and
fracture repair. J Cell Physiol. 215:578–587. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Glass DA II, Bialek P, Ahn JD, et al:
Canonical Wnt signaling in differentiated osteoblasts controls
osteoclast differentiation. Dev Cell. 8:751–764. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Morvan F, Boulukos K, Clement-Lacroix P,
et al: Deletion of a single allele of the Dkk1 gene leads to an
increase in bone formation and bone mass. J Bone Miner Res.
21:934–945. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Tian E, Zhan F, Walker R, et al: The role
of the Wnt-signaling antagonist DKK1 in the development of
osteolytic lesions in multiple myeloma. N Engl J Med.
349:2483–2494. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li ZG, Yang J, Vazquez ES, et al:
Low-density lipoprotein receptor-related protein 5 (LRP5) mediates
the prostate cancer-induced formation of new bone. Oncogene.
27:596–603. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Voorzanger-Rousselot N, Goehrig D, Journe
F, et al: Increased Dickkopf-1 expression in breast cancer bone
metastases. Br J Cancer. 97:964–970. 2007.PubMed/NCBI
|
|
40
|
Poon RT, Fan ST and Wong J: Clinical
implications of circulating angiogenic factors in cancer patients.
J Clin Oncol. 19:1207–1225. 2001.PubMed/NCBI
|
|
41
|
Fondevila C, Metges JP, Fuster J, et al:
p53 and VEGF expression are independent predictors of tumour
recurrence and survival following curative resection of gastric
cancer. Br J Cancer. 90:206–215. 2004. View Article : Google Scholar : PubMed/NCBI
|
